Results 121 to 130 of about 68,817 (283)
Status of myocardial antioxidants in ischemia–reperfusion injury [PDF]
Naranjan S. Dhalla
openalex +1 more source
Update on andrological effects of SARS‐CoV‐2 infection and COVID‐19: An overview review
Abstract Background Evidence indicates a wide range of andrological alterations in patients with the Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS‐CoV‐2) infection and Coronavirus Disease 2019 (COVID‐19). Aim To provide an update on the andrological effects of SARS‐CoV‐2 infection and COVID‐19.
Giuseppe Lisco+7 more
wiley +1 more source
Knockdown of Sfrp4 attenuates apoptosis to protect against myocardial ischemia/reperfusion injury
Secreted frizzled-related protein (Sfrp) 4 is a protein that involve in cardiac development and several cardiovascular diseases. However, the effect of Sfrp4 in mediating myocardial ischemia/reperfusion injury remains unknown.
Wenhui Zeng+5 more
doaj
Differential Regulation of mTOR Complexes with miR-302a Attenuates Myocardial Reperfusion Injury in Diabetes. [PDF]
Samidurai A+7 more
europepmc +1 more source
Fluosol in myocardial reperfusion injury
John J. Murray+3 more
openaire +2 more sources
M101 Hemoglobin enhances the mechanical and functional properties of rat heart and diaphragm muscles. Treated muscles exhibit improved contraction, reduced fatigue, and maintained function over time, suggesting potential clinical applications of M101 in preventing ischemia–reperfusion injury.
Ollivier Grimault+7 more
wiley +1 more source
(1) Background: Years of research have identified ischemic preconditioning (IPC) as a crucial endogenous protective mechanism against myocardial ischemia–reperfusion injury, enhancing the myocardial cell’s tolerance to subsequent ischemic damage.
Jia-Yuan Zhang+6 more
doaj +1 more source
Postconditioning with Nitrates Protects Against Myocardial Reperfusion Injury: A New Use for an Old Pharmacological Agent. [PDF]
Meng Z, Gai W, Song D.
europepmc +1 more source